Aortic Valve Replacement Devices Market Size Worth USD 19.01 Billion by 2034 | CAGR: 10.4%

The aortic valve replacement devices market size is expected to reach USD  19.01 Billion by 2034, according to a new study by Polaris Market Research. The report “Aortic Valve Replacement Devices Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Procedure, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Aortic valve replacement devices provide advanced treatment solutions for patients with aortic stenosis and other valvular heart diseases in hospitals, cardiac centers, and ambulatory surgical facilities. These include mechanical valves, biological valves, and transcatheter aortic valve replacement (TAVR) systems, supporting healthcare providers efficiently.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/aortic-valve-replacement-devices-market/request-for-sample

Market growth is driven by rising prevalence of cardiovascular diseases, aging population, and increasing awareness of minimally invasive procedures. Moreover, advances in TAVR and sutureless valve technologies improve patient outcomes and recovery.

Aortic Valve Replacement Devices Market Report Highlights

• Based on product type, mechanical valves dominated in 2024 due to durability and widespread use in traditional surgical procedures.
• In terms of procedure, open-heart surgery dominated in 2024 owing to established clinical outcomes and surgeon expertise.
• Based on end user, hospitals and clinics dominated in 2024 driven by high patient volumes and advanced cardiac care infrastructure.
• North America led in 2024, supported by advanced healthcare infrastructure, high patient awareness, and government-backed cardiac programs.
• Asia Pacific projected fastest CAGR, fueled by aging population, improving healthcare access, and increasing adoption of advanced procedures.
• Key players in the global market include Medtronic plc, Edwards Lifesciences Corp, Abbott Laboratories, JenaValve Technology, Inc., CryoLife, Inc., Boston Scientific Corporation, Pacific Medical, Inc., LifeTech Scientific Corp, HansBioMed, CorLife, MicroPort Scientific Corporation, and Corcym.

Polaris Market Research has segmented the market report based on product type, procedure, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020–2034)

• Mechanical Valves
• Biological Valves
• Transcatheter Aortic Valve Replacement (TAVR) Systems

By Procedure Outlook (Revenue, USD Billion, 2020–2034)

• Open-Heart Surgery
• Minimally Invasive Surgery

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Cardiovascular Centers

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America

• US
• Canada

• Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• Asia Pacific

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America